Century Sage Scientific Holdings Ltd (HK:1450)
:1450
Want to see HK:1450 full AI Analyst Report?
1450 Stock Chart & Stats
HK$1.14
HK$0.01(1.04%)
At close: 4:00 PM EST
HK$1.14
HK$0.01(1.04%)
Day’s Range― - ―
52-Week RangeHK$0.70 - HK$1.26
Previous CloseN/A
Volume562.00K
Average Volume (3M)1.96M
Market Cap
HK$1.20B
Enterprise ValueHK$759.62M
Total Cash (Recent Filing)HK$360.53M
Total Debt (Recent Filing)HK$93.33M
Price to Earnings (P/E)10.8
Beta0.43
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding1,407,203,100
10 Day Avg. Volume2,198,140
30 Day Avg. Volume1,964,156
Financial Highlights & Ratios
PEG Ratio1.42
Price to Book (P/B)2.65
Price to Sales (P/S)0.95
P/FCF Ratio4.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.24
Revenue Forecast (FY)HK$2.33B
Bulls Say, Bears Say
Bulls Say
Revenue ScalingSustained multi-year revenue expansion indicates the company is growing market share or product adoption. A larger, growing revenue base supports durable investment in R&D, sales capacity, and platform improvements, enabling longer-term competitive positioning and higher absolute cash generation.
Improved LeverageMaterial reduction in leverage meaningfully lowers financial risk and interest burden, increasing strategic flexibility. A stronger balance sheet supports sustained capex, M&A optionality, and resilience in downturns, making cash flows less vulnerable to credit markets over the medium term.
Stronger Cash GenerationA significant rebound to positive operating and free cash flow demonstrates improved cash conversion and internal funding ability. Reliable FCF enables reinvestment and reduces external financing needs, supporting durable growth initiatives and improving capital allocation flexibility.
Bears Say
Margin CompressionSustained margin erosion undermines the profitability of revenue growth and can erode return on capital even as sales expand. If driven by structural pricing pressure or rising input costs, lower margins reduce free cash flow sustainability and constrain long-term reinvestment and shareholder returns.
Inconsistent Cash FlowsVolatile operating and free cash flow makes planning and funding operations harder, increasing reliance on external financing in weak years. Persistent variability signals working-capital or execution issues that threaten the predictability of cash available for growth, dividends, or debt reduction.
Volatile Historical ReturnsLarge swings in returns indicate the business and capital structure have been in flux, reducing predictability of future earnings quality. Such volatility raises the risk that recent improvements are transient, complicating long-term forecasting and increasing execution risk for strategic initiatives.
Century Sage Scientific Holdings Ltd News
1450 FAQ
What was Century Sage Scientific Holdings Ltd’s price range in the past 12 months?
Century Sage Scientific Holdings Ltd lowest stock price was HK$0.70 and its highest was HK$1.26 in the past 12 months.
What is Century Sage Scientific Holdings Ltd’s market cap?
Century Sage Scientific Holdings Ltd’s market cap is HK$1.20B.
When is Century Sage Scientific Holdings Ltd’s upcoming earnings report date?
Century Sage Scientific Holdings Ltd’s upcoming earnings report date is Aug 31, 2026 which is in 71 days.
How were Century Sage Scientific Holdings Ltd’s earnings last quarter?
Century Sage Scientific Holdings Ltd released its earnings results on Mar 26, 2026. The company reported HK$0.026 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.026.
Is Century Sage Scientific Holdings Ltd overvalued?
According to Wall Street analysts Century Sage Scientific Holdings Ltd’s price is currently Overvalued.
Does Century Sage Scientific Holdings Ltd pay dividends?
Century Sage Scientific Holdings Ltd pays a Annually dividend of HK$0.05 which represents an annual dividend yield of N/A. See more information on Century Sage Scientific Holdings Ltd dividends here
What is Century Sage Scientific Holdings Ltd’s EPS estimate?
Century Sage Scientific Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Century Sage Scientific Holdings Ltd have?
Century Sage Scientific Holdings Ltd has 1,407,203,100 shares outstanding.
What happened to Century Sage Scientific Holdings Ltd’s price movement after its last earnings report?
Century Sage Scientific Holdings Ltd reported an EPS of HK$0.026 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.063%.
Which hedge fund is a major shareholder of Century Sage Scientific Holdings Ltd?
Currently, no hedge funds are holding shares in HK:1450
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Century Sage Scientific Holdings Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.08%
12-Months-Change
Fundamentals
Return on Equity
17.92%
Trailing 12-Months
Asset Growth
7.15%
Trailing 12-Months
Company Description
Century Sage Scientific Holdings Ltd
Be Friends Holding Ltd. functions as an investment firm, concentrating on providing integrated hardware and software solutions tailored for all-media applications. The company's activities are organized into distinct divisions: New Media Services, Application Solutions, System Maintenance Services, and the commercialization of its proprietary offerings. Established by Chi Sum Lo in 2007, its main corporate base is located in Hangzhou, China.
Technical Analysis
Xuan Wu Cloud Technology Holdings Limited
―
Sinopharm Tech Holdings Limited
―
YSB Inc.
―
Zhejiang Taimei Medical Technology Co Ltd Class H
―
Beijing Saimo Technology Co. Ltd. Class H
―
Options Prices
Currently, No data available
---